ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205,191 | -12.8% | 68,397 | +8.7% | 0.00% | – |
| Q2 2023 | $235,235 | +13.1% | 62,897 | +1.1% | 0.00% | – |
| Q1 2023 | $208,000 | +20494.1% | 62,213 | -70.4% | 0.00% | – |
| Q4 2022 | $1,010 | -99.9% | 210,018 | +13.5% | 0.00% | – |
| Q3 2022 | $1,053,000 | +232.2% | 185,044 | +314.9% | 0.00% | – |
| Q2 2022 | $317,000 | -80.0% | 44,605 | -79.7% | 0.00% | – |
| Q1 2022 | $1,586,000 | +285.9% | 219,600 | +378.2% | 0.00% | – |
| Q4 2021 | $411,000 | -73.3% | 45,920 | +4.7% | 0.00% | – |
| Q3 2021 | $1,537,000 | +157.9% | 43,850 | +58.3% | 0.00% | – |
| Q2 2021 | $596,000 | +17.8% | 27,707 | +238.0% | 0.00% | – |
| Q1 2021 | $506,000 | -69.0% | 8,198 | -79.0% | 0.00% | – |
| Q4 2020 | $1,634,000 | – | 39,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |